Theratechnologies Net Debt from 2010 to 2024

THTX Stock

USD 1.21 0.03 2.54%

Theratechnologies Net Debt yearly trend continues to be fairly stable with very little volatility. Net Debt is likely to outpace its year average in 2024. Net Debt is the total debt of Theratechnologies minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals

Net Debt

First Reported

1997-02-28

Previous Quarter

22.5 M

Current Value

23.1 M

Quarterly Volatility

17 M

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Theratechnologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Theratechnologies' main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.1 M, Total Revenue of 98.7 M or Gross Profit of 75 M, as well as many indicators such as Price To Sales Ratio of 0.56, Dividend Yield of 0.0 or Days Sales Outstanding of 62.42. Theratechnologies financial statements analysis is a perfect complement when working with Theratechnologies Valuation or Volatility modules.

Check out the analysis of Theratechnologies Correlation against competitors.

For more information on how to buy Theratechnologies Stock please use our How to Invest in Theratechnologies guide.

Latest Theratechnologies' Net Debt Growth Pattern

Below is the plot of the Net Debt of Theratechnologies over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. Theratechnologies' Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Theratechnologies' overall financial position and show how it may be relating to other accounts over time.

Net Debt

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Net Debt

Timeline

Theratechnologies Net Debt Regression Statistics

	Arithmetic Mean	16,289,037
	Geometric Mean	8,550,243
	Coefficient Of Variation	104.74
	Mean Deviation	15,121,083
	Median	9,620,044
	Standard Deviation	17,060,963
	Sample Variance	291.1T
	Range	48.8M
	R-Value	0.86
	Mean Square Error	79T
	R-Squared	0.75
	Significance	0.000032
	Slope	3,299,277
	Total Sum of Squares	4075.1T

Theratechnologies Net Debt History

	2024	30 M
	2023	28.6 M
	2022	24.9 M
	2021	42.9 M
	2020	36.3 M
	2019	42.6 M
	2018	22.1 M

Other Fundumenentals of Theratechnologies

Net Debt To E B I T D A

Theratechnologies Net Debt component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Short Term Investments	Current Deferred Revenue	Common Stock	Net Tangible Assets	Long Term Debt	Long Term Debt Total	Capital Surpluse	Property Plant Equipment	Net Invested Capital	Short Long Term Debt	Net Working Capital	Capital Stock	Deferred Long Term Liab
Total Assets		0.06	0.78	-0.57	0.94	0.77	0.84	0.94	0.28	0.84	0.51	-0.19	0.49	-0.51	0.9	0.83	0.72	0.59	0.8	0.84	0.35	0.51	0.27
Total Stockholder Equity	0.06		-0.46	0.57	0.11	-0.44	-0.44	-0.18	-0.46	0.32	0.26	-0.09	-0.6	0.76	-0.28	-0.39	-0.3	-0.68	0.5	0.25	0.64	-0.71	-0.85
Net Debt	0.78	-0.46		-0.74	0.78	0.85	0.92	0.86	0.48	0.53	0.37	-0.09	0.64	-0.81	0.85	0.86	0.79	0.91	0.4	0.64	-0.09	0.73	0.54
Retained Earnings	-0.57	0.57	-0.74		-0.4	-0.66	-0.74	-0.66	-0.41	-0.26	0.08	0.5	-0.66	0.72	-0.66	-0.69	-0.61	-0.75	-0.14	-0.28	0.14	-0.74	-0.67
Accounts Payable	0.94	0.11	0.78	-0.4		0.7	0.77	0.86	0.26	0.82	0.55	-0.03	0.36	-0.47	0.85	0.77	0.61	0.56	0.82	0.93	0.31	0.36	0.13
Net Receivables	0.77	-0.44	0.85	-0.66	0.7		0.95	0.9	0.29	0.54	0.42	-0.05	0.68	-0.79	0.86	0.92	0.85	0.87	0.41	0.45	0.08	0.8	0.66
Total Liab	0.84	-0.44	0.92	-0.74	0.77	0.95		0.96	0.43	0.56	0.38	-0.04	0.74	-0.86	0.95	0.98	0.77	0.9	0.51	0.6	0.06	0.82	0.65
Total Current Assets	0.94	-0.18	0.86	-0.66	0.86	0.9	0.96		0.32	0.69	0.52	-0.09	0.62	-0.68	0.94	0.94	0.76	0.77	0.69	0.71	0.26	0.7	0.46
Short Term Debt	0.28	-0.46	0.48	-0.41	0.26	0.29	0.43	0.32		0.08	0.05	-0.04	0.32	-0.5	0.33	0.34	0.29	0.34	0.0	0.38	-0.72	0.33	0.53
Intangible Assets	0.84	0.32	0.53	-0.26	0.82	0.54	0.56	0.69	0.08		0.42	-0.15	0.03	-0.22	0.63	0.56	0.56	0.26	0.82	0.78	0.49	0.11	-0.11
Short Term Investments	0.51	0.26	0.37	0.08	0.55	0.42	0.38	0.52	0.05	0.42		0.19	0.21	-0.01	0.35	0.33	0.5	0.25	0.49	0.46	0.29	0.18	-0.06
Current Deferred Revenue	-0.19	-0.09	-0.09	0.5	-0.03	-0.05	-0.04	-0.09	-0.04	-0.15	0.19		0.02	-0.1	0.03	0.03	-0.24	0.01	0.01	0.01	0.0	0.0	0.0
Common Stock	0.49	-0.6	0.64	-0.66	0.36	0.68	0.74	0.62	0.32	0.03	0.21	0.02		-0.77	0.73	0.72	0.58	0.8	0.04	0.17	-0.12	0.94	0.83
Net Tangible Assets	-0.51	0.76	-0.81	0.72	-0.47	-0.79	-0.86	-0.68	-0.5	-0.22	-0.01	-0.1	-0.77		-0.79	-0.85	-0.57	-0.91	-0.12	-0.32	0.26	-0.84	-0.81
Long Term Debt	0.9	-0.28	0.85	-0.66	0.85	0.86	0.95	0.94	0.33	0.63	0.35	0.03	0.73	-0.79		0.96	0.68	0.8	0.63	0.71	0.2	0.75	0.55
Long Term Debt Total	0.83	-0.39	0.86	-0.69	0.77	0.92	0.98	0.94	0.34	0.56	0.33	0.03	0.72	-0.85	0.96		0.69	0.87	0.56	0.6	0.16	0.79	0.6
Capital Surpluse	0.72	-0.3	0.79	-0.61	0.61	0.85	0.77	0.76	0.29	0.56	0.5	-0.24	0.58	-0.57	0.68	0.69		0.69	0.29	0.39	0.04	0.69	0.53
Property Plant Equipment	0.59	-0.68	0.91	-0.75	0.56	0.87	0.9	0.77	0.34	0.26	0.25	0.01	0.8	-0.91	0.8	0.87	0.69		0.16	0.35	-0.12	0.88	0.71
Net Invested Capital	0.8	0.5	0.4	-0.14	0.82	0.41	0.51	0.69	0.0	0.82	0.49	0.01	0.04	-0.12	0.63	0.56	0.29	0.16		0.85	0.65	0.04	-0.23
Short Long Term Debt	0.84	0.25	0.64	-0.28	0.93	0.45	0.6	0.71	0.38	0.78	0.46	0.01	0.17	-0.32	0.71	0.6	0.39	0.35	0.85		0.23	0.14	-0.05
Net Working Capital	0.35	0.64	-0.09	0.14	0.31	0.08	0.06	0.26	-0.72	0.49	0.29	0.0	-0.12	0.26	0.2	0.16	0.04	-0.12	0.65	0.23		-0.12	-0.47
Capital Stock	0.51	-0.71	0.73	-0.74	0.36	0.8	0.82	0.7	0.33	0.11	0.18	0.0	0.94	-0.84	0.75	0.79	0.69	0.88	0.04	0.14	-0.12		0.88
Deferred Long Term Liab	0.27	-0.85	0.54	-0.67	0.13	0.66	0.65	0.46	0.53	-0.11	-0.06	0.0	0.83	-0.81	0.55	0.6	0.53	0.71	-0.23	-0.05	-0.47	0.88

Click cells to compare fundamentals

About Theratechnologies Financial Statements

Theratechnologies investors use historical fundamental indicators, such as Theratechnologies' Net Debt, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Theratechnologies. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Net Debt	28.6 M	30 M
Net Debt To EBITDA	(2.90)	(3.05)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for Theratechnologies Stock Analysis

When running Theratechnologies' price analysis, check to measure Theratechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theratechnologies is operating at the current time. Most of Theratechnologies' value examination focuses on studying past and present price action to predict the probability of Theratechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theratechnologies' price. Additionally, you may evaluate how the addition of Theratechnologies to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Theratechnologies Net Debt from 2010 to 2024

Latest Theratechnologies' Net Debt Growth Pattern

Theratechnologies Net Debt Regression Statistics

Theratechnologies Net Debt History

Other Fundumenentals of Theratechnologies

Theratechnologies Net Debt component correlations

About Theratechnologies Financial Statements

Also Currently Popular

Additional Tools for Theratechnologies Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY